Literature DB >> 9949221

Immunohistochemical localization of erythropoietin and its receptor in the developing human brain.

S E Juul1, A T Yachnis, A M Rojiani, R D Christensen.   

Abstract

We have previously shown erythropoietin (Epo) and its receptor (Epo-R) to be present in the fetal human central nervous system (CNS), and Epo to be present in the spinal fluid of normal preterm and term infants. To investigate the cellular specificities and developmental patterns of expression of these polypeptides in the human brain-areas that have not been well researched-we designed the following study. Human brains ranging in maturity from 5 weeks post-conception to adult were preserved at the time of elective abortion, surgical removal (tubal pregnancy, or removal for temporal lobe epilepsy), or autopsy. Immunohistochemistry was used to localize Epo and Epo-R reactivity in brains of different stages of development. Astrocytes, neurons, and microglia were identified in sequential tissue sections by specific antibodies. At 5 to 6 weeks post-conception, both Epo and Epo-R localized to cells in the periventricular germinal zone. At 10 weeks post-conception, Epo immunoreactivity was present throughout the cortical wall, with the most intense immunoreactivity present in the ventricular and subventricular zones. Epo-R, in contrast, was localized primarily to the subventricular zone, with little staining evident in the ventricular zone. In late fetal brains, Epo-R reactivity was most prominent in astrocytic cells, although modest reactivity was observed in certain neuron populations. In contrast, Epo staining localized primarily to neurons in fetal brains, although a subpopulation of astrocytes was also immunoreactive. In postnatal brains, both astrocyte and neuron populations were immunoreactive with antibodies to Epo-R and Epo. From these results it is clear that Epo and its receptor are present in the developing human brain as early as 5 weeks post-conception, and each protein shows a specific distribution that changes with development. We speculate that Epo is important in neurodevelopment, and that it also plays a role in brain homeostasis later in life, functioning in an autocrine or paracrine manner.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9949221     DOI: 10.1007/s100249900103

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  45 in total

1.  Pyruvate protects the brain against ischemia-reperfusion injury by activating the erythropoietin signaling pathway.

Authors:  Myoung-Gwi Ryou; Ran Liu; Ming Ren; Jie Sun; Robert T Mallet; Shao-Hua Yang
Journal:  Stroke       Date:  2012-01-26       Impact factor: 7.914

2.  White matter changes in patients with friedreich ataxia after treatment with erythropoietin.

Authors:  Karl Egger; Christian Clemm von Hohenberg; Michael F Schocke; Charles R G Guttmann; Demian Wassermann; Marlene C Wigand; Wolfgang Nachbauer; Christian Kremser; Brigitte Sturm; Barbara Scheiber-Mojdehkar; Marek Kubicki; Martha E Shenton; Sylvia Boesch
Journal:  J Neuroimaging       Date:  2013-09-09       Impact factor: 2.486

Review 3.  The neurobiology of erythropoietin.

Authors:  Arthur J Sytkowski
Journal:  Cell Mol Neurobiol       Date:  2011-05-03       Impact factor: 5.046

Review 4.  Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection.

Authors:  Vijayeta Rangarajan; Sandra E Juul
Journal:  Pediatr Neurol       Date:  2014-06-24       Impact factor: 3.372

5.  Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells.

Authors:  T Shingo; S T Sorokan; T Shimazaki; S Weiss
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

6.  Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF alpha release.

Authors:  Lusine Danielyan; Ali Lourhmati; Stephan Verleysdonk; Daniela Kabisch; Barbara Proksch; Ulrike Thiess; Sumaira Umbreen; Boris Schmidt; Christoph H Gleiter
Journal:  Neurochem Res       Date:  2007-04-04       Impact factor: 3.996

7.  Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia.

Authors:  Rohit Kumar; Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Korean J Physiol Pharmacol       Date:  2010-10-31       Impact factor: 2.016

8.  Erythropoietin as a neuroprotectant for neonatal brain injury: animal models.

Authors:  Christopher M Traudt; Sandra E Juul
Journal:  Methods Mol Biol       Date:  2013

Review 9.  Erythropoietin and Neonatal Neuroprotection.

Authors:  Sandra E Juul; Gillian C Pet
Journal:  Clin Perinatol       Date:  2015-05-14       Impact factor: 3.430

Review 10.  Neuroprotection in the newborn infant.

Authors:  Fernando F Gonzalez; Donna M Ferriero
Journal:  Clin Perinatol       Date:  2009-12       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.